MELINDA ROGERS: Open Payments
NPI 1801268529 · SUMMERFIELD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 24 payments from 10 companies in 2025. Trend: 2023 $436 · 2024 $594 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $264 |
| AstraZeneca Pharmaceuticals LP | 2 | $139 |
| Lilly USA, LLC | 3 | $47 |
| Axsome Therapeutics, Inc. | 1 | $40 |
| Amgen Inc. | 2 | $34 |
| PhotoniCare Inc | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| SANOFI PASTEUR INC. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| SHIELD THERAPEUTICS INC | 1 | $14 |
Products named: VRAYLAR, BREZTRI, QULIPTA, UBRELVY, Auvelity, MOUNJARO, OtoSight Middle Ear Scope, CAPLYTA.
Industry payments across FL — which companies pay providers there.
